Ceribell, Inc. (CBLL)
21.00
+0.59
(+2.89%)
USD |
NASDAQ |
Dec 12, 14:43
Ceribell EPS Diluted (Quarterly): -0.3658 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
| Myomo, Inc. | -0.0869 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.46M |
| Revenue (Quarterly) | 22.59M |
| Total Expenses (Quarterly) | 36.05M |
| Enterprise Value | 609.93M |
| Gross Profit Margin (Quarterly) | 88.28% |
| Profit Margin (Quarterly) | -59.61% |
| Earnings Yield | -6.90% |
| Normalized Earnings Yield | -6.798 |